Undoubtedly, one of the diseases that causes the most deaths per year is cancer. Despite the fact that its existence is thousands of years old, doctors find it very difficult to discover a cure and attempts have been made to find some kind of remedy for a long time. However, the paradigm changed with the finding made by some researchers from Harvard University.
Specialists understand that the disease spreads through the spread of diseased blood to the rest of the body. This is what is known as metastasis: the cancer it starts in one part of the body and can end in another part. That is why they thought that if they develop a vaccine that could stop this advance, there would be many fewer patients.
The vaccine was successful in eliminating cancerous tumors in mice
–
The antidote was first tested on animals that were infested with cancer. These had several tumors and considered that the dose could eradicate them. Indeed, that is what happened: in the mice that were injected, the tumors shrank to almost nothing. Undoubtedly, a great find for the science and the scientific community.
“Here we present a cancer vaccine that induces a coordinated attack by diverse populations of T cells and natural killer (NK) cells. Antibodies increase the density of MICA/B proteins on the surface of tumor cells, enhance the presentation of tumor antigens by dendritic cells to T cells”expressed one of the specialists.
—
A radical deputy who has breast cancer went to the session in the middle of chemotherapy and received a big applause
Deputy Jimena Latorre is undergoing chemotherapy treatment to battle breast cancer. Sergio Massa asked for applause and the rest of the legislators expressed their support for him.
–
–
Look: The moving gesture of a young man with his girlfriend with cancer
What is striking about the discovery is that it can be adapted to different types of cancer, so many patients could benefit. “It does not depend on the specific mutations in each patient’s cancer. The main message is that it is possible to develop vaccines that work in many patients and in different tumor types”, the researchers concluded.
